Skaana Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Skaana Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-20,877	Closed	-$387K	–	215
2023 Q3	$387K	Buy	20,877 +1,000	+5%	+$11.3K	0.1%	85
2023 Q2	$220K	Sell	19,877 -4,000	-17%	-$55.7K	0.05%	99
2023 Q1	$321K	Buy	23,877 +6,500	+37%	+$112K	0.1%	77
2022 Q4	$215K	Buy	17,377 +4,423	+34%	+$62.6K	0.05%	82
2022 Q3	$181K	Buy	+12,954	New	+$209K	0.06%	50

Skaana Management's ICPT Position: Q4 2023 in Review

Skaana Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 20,877 shares — an estimated $387K sold.

Skaana Management first reported a position in ICPT in Q3 2022 and held it in 5 quarters. The position peaked at $387K in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

Skaana Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
Skaana Management sold 20,877 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $387K.
Skaana Management first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2022 and held it in 5 quarters.
Skaana Management's Intercept Pharmaceuticals, Inc. position peaked at $387K in Q3 2023.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Skaana Management's 13F filing for Q4 2023, filed 14 Feb 2024.